FIELD: medicine.
SUBSTANCE: group of invention refers to medicine and can be used for treating anaphylaxis in a patient in need thereof. That is ensured by administering an effective amount of a combination of levocetirizine and montelukast to said patient. Above-mentioned combination is administered if observing the symptoms of anaphylaxis. Also disclosed are a method of treating the symptoms of anaphylaxis and a method of reducing duration of anaphylaxis in a patient.
EFFECT: group of inventions provides effective relief of the patient's anaphylaxis symptoms.
22 cl, 1 dwg, 9 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF LEVOCETIRIZINE AND MONTELUKAST IN TREATMENT OF TRAUMATIC INJURY | 2014 |
|
RU2672871C2 |
| NEW COMBINATION OF ANTI-HISTAMINE AGENTS HAVING NO SEDATIVE ACTION WITH COMPOUNDS EFFECTING TO LEUKOTRIEN ACTION FOR RHINITIS/CONJUNCTIVITIS TREATMENT | 2001 |
|
RU2292208C2 |
| NEW ANTIALLERGIC ANTIPHLOGISTIC COMPOSITION AND METHOD FOR ITS OBTAINING | 1998 |
|
RU2188007C2 |
| DERIVATIVES OF 1-AMINO-ALKYLCYCLOHEXANE FOR TREATMENT OF DISEASES, MEDIATED BY MAST CELLS | 2009 |
|
RU2484813C2 |
| COMBINATION OF R,R-GLYCOPYRROLATE AND MONTELUKAST FOR TREATMENT OF RESPIRATORY DISEASES AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2420285C2 |
| IMPROVED VEGETABLE COMPOSITION POSSESSING ANTI-ALLERGIC PROPERTY AND METHOD FOR ITS PREPARING | 2001 |
|
RU2264224C2 |
| SOPHORAE SUBPROSTRATAE RADIX EXTRACT FOR PREVENTION AND TREATMENT OF RESPIRATORY DISEASES | 2005 |
|
RU2390349C2 |
| METHODS OF TREATING CHRONIC SPONTANEOUS URTICARIA USING BRUTON TYROSINE KINASE INHIBITOR | 2020 |
|
RU2818678C2 |
| USE OF LGG FOR PREVENTION OR TREATMENT OF RESPIRATORY ALLERGIES | 2006 |
|
RU2435598C2 |
| COMPOSITION CONTAINING EXTRACT OR FRACTION FROM JUSTICIA PLANT | 2015 |
|
RU2671501C1 |
